DYRK1B and ovarian cancer: Recently, it has been reported that Mirk/Dyrk1B functions independently and additively to regulate the exit of cancer cells from quiescence through regulating cyclin D turnover and p27kip1 stabilization in colon, pancreatic and ovarian cancer cells shown by Mirk-depletion studies [5-7].